Dr. Caroline Dealy of UCONN Health gives an inside scoop about her research on the development of the human skeleton. This regenerative research involves human embryonic and induced pluripotent stem cell. Dr. Dealy explains the role of genetics in these stem cells. She shares her insight on these incredible potential medical treatments for people that have lost limbs. We also discuss her role as the director of the Skeletal, Biology and Regeneration Graduate Program and what she is teaching her students in anticipation of how this field is changing.
Dr. Caroline Dealy is an associate professor at Uconn Health in the Center for Regenerative Medicine and Skeletal Development, Department of Reconstructive Sciences, School of Dental Medicine. Dr. Dealy received her Ph.D. in Developmental Biology from the UCONN. Dr. Dealy is also a member of the UConn Musculoskeletal Institute and the UConn Stem Cell Institute. She is a faculty member in the Genetics and Developmental Biology Graduate Program. She is the Director of the Skeletal, Biology and Regeneration Graduate Program. Dr. Dealy is a founder of the Connecticut biotechnology startup company Chondrogenics, Inc., and a 2012 Connecticut Women of Innovation Award finalist. She is also the founder and director of the UConn-TIP Technology Intern Program
(Photo and Bio Credit: UCONN Health